Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice
Sara Ranjbarvaziri(Unknown), Jin Yang(Rapt Therapeutics (United States)), Aliya Zeng, Francis Grafton, Farshad Farshidfar(Institute for Stem Cell Biology and Regenerative Medicine), Ana Budan, Cindy Li, Xiaomei Song, Charles Mackay, Gretchen Argast(Rapt Therapeutics (United States)), Iris Wu(University of Michigan), James R. Priest(Cardiovascular Institute of the South), Timothy Hoey, Mohammad A. Mandegar(Vital Therapies (United States)), Reva Shenwai, Matthew Kozubov, Emma Xu(Columbia University), Melissa Van Pell, Amara Greer-Short(Unknown)
Cited by 50
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
|British Journal of Cancer|2016|136
Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication
|Journal of Biological Chemistry|2004|104
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state
|Proceedings of the National Academy of Sciences|2021|81